Intuitive Surgical (ISRG) Cash & Equivalents (2009 - 2026)

Intuitive Surgical has reported Cash & Equivalents for 18 years, with the latest figure at $2.8 billion in Q2 2026.

• On a quarterly basis, Cash & Equivalents fell 19.91% year-over-year to $2.8 billion in Q2 2026; TTM through Jun 2026 was $2.8 billion, a 19.91% decrease from a year earlier, with the FY2025 full-year figure at $3.4 billion, up 63.3% from the prior year.
• Cash & Equivalents was $2.8 billion for Q2 2026 at Intuitive Surgical, up from $2.0 billion in the prior quarter.
• The five-year high for Cash & Equivalents was $3.6 billion in Q3 2023, with the low at $1.1 billion in Q1 2022.
• Average Cash & Equivalents over 5 years is $2.5 billion, with a median of $2.7 billion recorded in 2025.
• The sharpest annual moves came in 2023 and 2024: Cash & Equivalents jumped 134.2% in 2023, then plunged 32.08% in 2024.
• Over 5 years, Cash & Equivalents stood at $1.6 billion in 2022, then jumped by 75.19% to $2.8 billion in 2023, then decreased by 25.55% to $2.1 billion in 2024, then surged by 63.3% to $3.4 billion in 2025, then fell by 18.04% to $2.8 billion in 2026.
• The last three Cash & Equivalents figures came in at $2.8 billion (Q2 2026), $2.0 billion (Q1 2026), and $3.4 billion (Q4 2025), per Business Quant data.